Report Highlights
The global market for elder-care technology products was approximately $2.7 billion in 2012. It is expected to grow to roughly $3.2 billion by 2013 and $7.2 billion by 2018 at a compound annual growth rate (CAGR) from 2013 to 2018 of 17.7%.
Report Includes
- An overview of the global market for long-term care and home healthcare technologies, with a focus on remote health-monitoring and safety-monitoring systems.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Discussion of how changing medical needs driven by an aging population, the necessity to cut costs in the delivery of care, and further adoption of technology and broadband connectivity by seniors will accelerate future demand for remote monitoring devices and home safety technology.
- Examination of the regulatory framework that controls the introduction of new remote monitoring devices in varied long-term-care settings.
- Ways to increase interoperability of consumer medical products.
Report Scope
This report is a business analysis with the primary purpose of examining the potential market for elder-care technologies, specifically home telehealth and safety monitoring. The report includes sections on:
- Descriptions of home telehealth and safety-monitoring technologies and drivers of their adoption.
- Current status of the long-term care environment, including trends and factors affecting growth.
- Current and projected market status of these technologies.
- General regulatory and standards overview.
- Patent trend analysis.
- Information on the industry players.
Analyst Credentials
Andrew McWilliams spent more than 25 years as a consultant with Ernst & Young, McKinsey & Company and A.T. Kearny focused on manufacturing before segueing into research analysis. He has been covering myriad technology categories for BCC Research for more than 15 years. McWilliams has a BA from Princeton University and an MA from Harvard University. He has worked in more than 40 countries and he resides in the greater Boston area.
Report Highlights
-
The global market for elder-care technology products is worth approximately $2.6 billion in 2010 and should grow to about $4 billion in 2015, at a compound annual growth rate (CAGR) from 2010 to 2015 of 8.7%.
-
Safety monitoring technologies are valued at $2.3 billion in 2010 and are expected to reach $3.4 billion by 2015, a compound annual growth rate of 8.2%
-
Home telehealth technologies are worth $371 million in 2010 and are expected to increase at a compound annual growth rate (CAGR) of 11.2% to reach $631 million in 2015.
Related Reports
Antiaging Products and Services: The Global Market
The total market for antiaging products and services was valued at $249.3 billion in 2012. This is expected to increase to nearly $261.9 billion by the end of 2013 and $345.8 billion in 2018, a compound annual growth rate (CAGR) of 5.7% between 2013 and 2018.
Disabled and Elderly Assistive Technologies
The U.S. market for assistive technologies is projected to grow from nearly $43.4 billion (including eyeglasses and contact lenses) in 2012 to $45.9 billion in 2013 and nearly $60.5 billion in 2018, a compound annual growth rate (CAGR) of 5.7% between 2013 and 2018.
Regenerative Medicines: Bone and Joint Applications
The U.S. market for regenerative medicine products used in bone and joint applications was estimated to total $2.72 billion in 2012 and is projected to increase to $2.73 billion in 2013. The market should total nearly $3.9 billion by 2018 and have a five-year compound annual growth rate (CAGR) of 7.3%.
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets
The global market for alzheimer’s disease reached $10.2 billion in 2012. The market is expected to decrease to $9.5 billion in 2017 for a CAGR of -1.5%.
Recent Reports
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
Global Oncology Pharmaceuticals Market
The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More